Author

Matthew Larson

Massachusetts General HospitalPrimary ORCID profile (0000-0002-1125-6760 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Matthew LarsoniD1 paper · University of Wisconsin–Madison

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Abucar Mohamed· 1 shared Alison M. MaleiD· 1 shared Aloysius DomingoiD· 1 shared Amjad Ullah KhaniD· 1 shared Amy E. Crunk· 1 shared Ana Cristina Victorino KrepischiiD· 1 shared Andrée Delahaye‐DurieziD· 1 shared Ange‐Line BrueliD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Abucar Mohamed

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Clinical, in vitro, and in vivo evidence of WAPL as a novel cohesinopathy gene and phenotypic driver of 10q22.3q23.2 genomic disorder

Philip M. Boone, Serkan Erdin, Abucar Mohamed, Sadegheh Haghshenas, Kamli N. W. Faour, Emeline M. Kao, Jack M. Fu, Chiara Auwerx, Ricardo Harripaul, Bimal Jana, Danielle Springer, Grey F. Hallström, Celine E. de Esch, Erica Rose Denhoff, Lauren Holmes, , Ilaria Parenti

The paper identifies WAPL as a novel cohesinopathy gene and driver of a genomic disorder, showing its role in developmental delay and other anomalies through clinical, in vitro, and in vivo analyses.

medRxiv · Feb 28, 2026 · PreprintGenetic & Genomic Medicine